BioMarin Pharmaceutical (BMRN) Earnings Date, Estimates & Call Transcripts $69.73 -0.66 (-0.94%) (As of 10/25/2024 08:56 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 29After Market ClosesConfirmedActual EPS (Aug. 5) $0.77 Beat By $0.39 Consensus EPS (Aug. 5) $0.38 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBMRN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BMRN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIHere’s how to start a “Weekend Side Hustle” from your sofaHere’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand. And that’s how you can kickstart your very own “Weekend Side Hustle!” Now that you know that…Let me show you how I target extra income as early as THIS weekend! BioMarin Pharmaceutical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.36$0.36$0.36 Q2 20242$0.36$0.61$0.49 Q3 20243$0.53$0.71$0.65 Q4 20243$0.55$0.71$0.63 FY 202410$1.80$2.39$2.12 Q1 20253$0.49$0.71$0.60 Q2 20253$0.61$0.83$0.75 Q3 20253$0.65$0.85$0.78 Q4 20253$0.66$0.87$0.79 FY 202512$2.41$3.26$2.92 Q1 20261$0.73$0.73$0.73 Q2 20261$0.80$0.80$0.80 BMRN Earnings Date and InformationBioMarin Pharmaceutical last posted its earnings data on August 5th, 2024. The biotechnology company reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.38 by $0.39. The company had revenue of $712.03 million for the quarter, compared to analysts' expectations of $660.51 million. BioMarin Pharmaceutical has generated $1.07 earnings per share over the last year ($1.07 diluted earnings per share) and currently has a price-to-earnings ratio of 52.4. Earnings for BioMarin Pharmaceutical are expected to grow by 34.31% in the coming year, from $2.39 to $3.21 per share. BioMarin Pharmaceutical has confirmed that its next quarterly earnings report will be published on Tuesday, October 29th, 2024. BioMarin Pharmaceutical will be holding an earnings conference call on Tuesday, October 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call. or dial in at 609-800-9909 with passcode "4980126". Read More BioMarin Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/29/2024(Confirmed)------- 8/5/2024Q2 2024$0.38$0.77+$0.39$0.99$660.51 million$712.03 million4/24/2024Q1 2024$0.37$0.49+$0.12$0.52$649.75 million$648.83 million 2/22/2024Q4 2023$0.4450$0.49+$0.0450$0.41$639.53 million$646.21 million 11/1/2023Q3 2023$0.28$0.26($0.02)$0.31$603.51 million$581.33 million 7/31/2023Q2 2023$0.24$0.34+$0.10$0.39$591.46 million$595.28 million 4/26/2023Q1 2023$0.24$0.39+$0.15$0.51$572.53 million$596.42 million Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover2/27/2023Q4 2022$0.12$0.11($0.01)$0.22$533.88 million$537.54 million 10/26/2022Q3 2022$0.12$0.16+$0.04$0.36$516.03 million$505.30 million 8/3/2022Q2 2022$0.20$0.33+$0.13$0.51$514.18 million$533.80 million 4/27/2022Q1 2022$0.15$0.31+$0.16($0.01)$505.11 million$519.36 million 2/23/2022Q4 2021($0.22)($0.21)+$0.01($0.10)$442.38 million$449.81 million 10/26/2021Q3 2021($0.25)($0.20)+$0.05$0.14$435.29 million$408.74 million 7/27/2021Q2 2021($0.11)$0.07+$0.18$0.39$448.84 million$501.69 million 4/28/2021Q1 2021$0.07$0.09+$0.02$0.49$445.44 million$486.03 million 2/25/2021Q4 2020($0.06)$0.12+$0.18($0.22)$447.17 million$452.12 million 11/5/2020Q3 2020($0.01)$4.01+$4.02($3.43)$454.64 million$476.78 million 8/4/2020Q2 2020($0.10)$0.07+$0.17$0.30$418.02 million$429.49 million 4/29/2020Q1 2020$0.12$0.44+$0.32$0.32$468.77 million$502.07 million 2/26/2020Q4$0.01$0.08+$0.07$0.10$461.88 million$454.44 million BioMarin Pharmaceutical Earnings - Frequently Asked Questions When is BioMarin Pharmaceutical's earnings date? BioMarin Pharmaceutical has confirmed that its next quarterly earnings data will be published on Tuesday, October 29th, 2024. Learn more on BMRN's earnings history. What guidance has BioMarin Pharmaceutical issued on next quarter's earnings? BioMarin Pharmaceutical updated its FY 2024 earnings guidance on Tuesday, September, 24th. The company provided earnings per share guidance of 3.100-3.250 for the period, compared to the consensus EPS estimate of 2.040. The company issued revenue guidance of $2.8 billion-$2.8 billion, compared to the consensus revenue estimate of $2.8 billion. Did BioMarin Pharmaceutical beat their earnings estimates last quarter? In the previous quarter, BioMarin Pharmaceutical (NASDAQ:BMRN) reported $0.77 earnings per share (EPS) to beat the analysts' consensus estimate of $0.38 by $0.39. Learn more on analysts' earnings estimate vs. BMRN's actual earnings. How much revenue does BioMarin Pharmaceutical generate each year? BioMarin Pharmaceutical (NASDAQ:BMRN) has a recorded annual revenue of $2.59 billion. How much profit does BioMarin Pharmaceutical generate each year? BioMarin Pharmaceutical (NASDAQ:BMRN) has a recorded net income of $167.65 million. BMRN has generated $1.07 earnings per share over the last four quarters. What is BioMarin Pharmaceutical's price-to-earnings ratio? BioMarin Pharmaceutical (NASDAQ:BMRN) has a trailing price-to-earnings ratio of 52.43 and a forward price-to-earnings ratio of 29.18. The price/earnings-to-growth ratio is 0.81. What is BioMarin Pharmaceutical's EPS forecast for next year? BioMarin Pharmaceutical's earnings are expected to grow from $2.39 per share to $3.21 per share in the next year, which is a 34.31% increase. ` More Earnings Resources from MarketBeat Related Companies SRPT Earnings Date TEVA Earnings Date VYGR Earnings Date ALNY Earnings Date BIIB Earnings Date UTHR Earnings Date INCY Earnings Date EXAS Earnings Date NBIX Earnings Date EXEL Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat This page (NASDAQ:BMRN) was last updated on 10/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredCountdown to Chaos begins WednesdayWill it be Trump or Harris? In an exclusive interview on Wednesday, October 30, at 8 p.m. ET, he’ll explain...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)27 of the world's brightest minds in crypto are gathering to reveal their top picks and predictions for the ma...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding BioMarin Pharmaceutical Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
